• Study on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Spain

  • Study on the Safety and Effects of AUTO1, Cyclophosphamide, and Fludarabine Phosphate in Children with Relapsed or Refractory B-cell Leukemia and Non-Hodgkin Lymphoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Duloxetine for Reducing Chronic Pain After Inguinal Hernia Surgery in High-Risk Patients

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Pain Relief After Lumbar Spinal Surgery Using Erector Spinae Plane Block with Etoricoxib and Drug Combination for Patients Undergoing Lumbar Arthrodesis

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium

  • Study on the Effects of Rotigotine and Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Italy Spain

  • Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Estonia Finland France Germany +8

  • Study on Weaning Patients with Acute Respiratory Failure from High-Flow Nasal Oxygen Therapy Using Oxygen

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Vitamin D Deficiency Treatment in Obese Children and Adolescents Using Colecalciferol: Comparing Monthly Boluses and Daily Doses

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on High-Risk Prostate Cancer Treatment Using Darolutamide, Relugolix, and Drug Combination for Eligible Patients

    Recruiting

    4 1 1
    Investigated drugs:
    Belgium Spain

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

powered by